{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:43:10Z","timestamp":1790998990041,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1245\/s10434-023-13316-7","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:03:24Z","timestamp":1681297404000},"page":"4279-4289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Favorable Prognostic Factors for Survival Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis After Hepatectomy"],"prefix":"10.1245","volume":"30","author":[{"given":"Sang-Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok-Bog","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo-Han","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Gyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Yong","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi-Won","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hwan","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil-Chun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Gon","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geunhyeok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rak-kyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"13316_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijsu.2015.05.009","volume":"20","author":"ZM Zhang","year":"2015","unstructured":"Zhang ZM, Lai ECH, Zhang C, et al. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. Int J Surg. 2015;20:8\u201316. https:\/\/doi.org\/10.1016\/j.ijsu.2015.05.009.","journal-title":"Int J Surg."},{"issue":"5","key":"13316_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000348325","volume":"84","author":"WY Lau","year":"2013","unstructured":"Lau WY, Sangro B, Chen PJ, et al. Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: The emerging role for radioembolization using yttrium-90. Oncol. 2013;84(5):311\u20138. https:\/\/doi.org\/10.1159\/000348325.","journal-title":"Oncol."},{"issue":"1","key":"13316_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/s1665-2681(19)30797-5","volume":"14","author":"MDC Manzano-Robleda","year":"2015","unstructured":"Manzano-Robleda MDC, Barranco-Fragoso B, Uribe M, et al. Portal vein thrombosis: What is new? Ann Hepatol. 2015;14(1):20\u20137. https:\/\/doi.org\/10.1016\/s1665-2681(19)30797-5.","journal-title":"Ann Hepatol."},{"issue":"20","key":"13316_CR4","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/nejmoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382(20):1894\u2013905. https:\/\/doi.org\/10.1056\/nejmoa1915745.","journal-title":"N Engl J Med."},{"issue":"1","key":"13316_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"PR Galle","year":"2018","unstructured":"Galle PR, Forner A, Llovet JM, et al. EASL Clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019.","journal-title":"J Hepatol."},{"issue":"5","key":"13316_CR6","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.ijrobp.2011.03.019","volume":"82","author":"SM Yoon","year":"2012","unstructured":"Yoon SM, Lim YS, Won HJ, et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: Long-term patient outcomes. Int J Radiat Oncol Biol Phys. 2012;82(5):2004\u201311. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.03.019.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"13316_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1245\/s10434-010-1321-8","volume":"18","author":"J Luo","year":"2011","unstructured":"Luo J, Guo RP, Lai ECH, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: A prospective comparative study. Ann Surg Oncol. 2011;18(2):413\u201320. https:\/\/doi.org\/10.1245\/s10434-010-1321-8.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"13316_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.amjsurg.2014.09.041","volume":"210","author":"B Pesi","year":"2015","unstructured":"Pesi B, Ferrero A, Grazi GL, et al. Liver resection with thrombectomy as a treatment of hepatocellular carcinoma with major vascular invasion: Results from a retrospective multicentric study. Am J Surg. 2015;210(1):35\u201344. https:\/\/doi.org\/10.1016\/j.amjsurg.2014.09.041.","journal-title":"Am J Surg."},{"issue":"5","key":"13316_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s12072-020-10032-2","volume":"14","author":"ZH Chen","year":"2020","unstructured":"Chen ZH, Zhang XP, Lu YG, et al. Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study. Hepatol Int. 2020;14(5):754\u201364. https:\/\/doi.org\/10.1007\/s12072-020-10032-2.","journal-title":"Hepatol Int."},{"issue":"19","key":"13316_CR10","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1002\/cncr.26561","volume":"118","author":"ZW Peng","year":"2012","unstructured":"Peng ZW, Guo RP, Zhang YJ, et al. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer. 2012;118(19):4725\u201336. https:\/\/doi.org\/10.1002\/cncr.26561.","journal-title":"Cancer."},{"issue":"11","key":"13316_CR11","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s11605-009-0998-0","volume":"13","author":"D Ban","year":"2009","unstructured":"Ban D, Shimada K, Yamamoto Y, et al. Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein. J Gastrointest Surg. 2009;13(11):1921\u20138. https:\/\/doi.org\/10.1007\/s11605-009-0998-0.","journal-title":"J Gastrointest Surg."},{"key":"13316_CR12","unstructured":"Liver Cancer Study Group of Japan. The general rules for the clinical and Pathological Study of Primary Liver Cancer. 3rd Englis. Tokyo Kanehara & Co., Ltd; 2010."},{"issue":"3","key":"13316_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/s1365-182x(17)30755-4","volume":"2","author":"SM Strasberg","year":"2000","unstructured":"Strasberg SM, Belghiti J, Clavien P-A, et al. The brisbane 2000 terminology of liver anatomy and resections. HPB. 2000;2(3):333\u20139. https:\/\/doi.org\/10.1016\/s1365-182x(17)30755-4.","journal-title":"HPB."},{"issue":"1","key":"13316_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.surg.2008.09.005","volume":"145","author":"Y Inoue","year":"2009","unstructured":"Inoue Y, Hasegawa K, Ishizawa T, et al. Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery. 2009;145(1):9\u201319. https:\/\/doi.org\/10.1016\/j.surg.2008.09.005.","journal-title":"Surgery."},{"key":"13316_CR15","doi-asserted-by":"publisher","unstructured":"Cheng A-L, Qin S, Ikeda M, et al. IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC). Ann Oncol. 2019;30(November):ix186-ix187. https:\/\/doi.org\/10.1093\/annonc\/mdz446.002","DOI":"10.1093\/annonc\/mdz446.002"},{"issue":"5","key":"13316_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jhep.2016.05.044","volume":"65","author":"T Kokudo","year":"2016","unstructured":"Kokudo T, Hasegawa K, Matsuyama Y, et al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol. 2016;65(5):938\u201343. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.044.","journal-title":"J Hepatol."},{"issue":"2","key":"13316_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jss.2011.03.072","volume":"175","author":"JS Chen","year":"2012","unstructured":"Chen JS, Wang Q, Chen XL, et al. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis. J Surg Res. 2012;175(2):243\u201350. https:\/\/doi.org\/10.1016\/j.jss.2011.03.072.","journal-title":"J Surg Res."},{"issue":"1","key":"13316_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3748\/wjg.v21.i1.246","volume":"21","author":"Y Yamamoto","year":"2015","unstructured":"Yamamoto Y, Ikoma H, Morimura R, et al. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2015;21(1):246\u201353. https:\/\/doi.org\/10.3748\/wjg.v21.i1.246.","journal-title":"World J Gastroenterol."},{"issue":"4","key":"13316_CR19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s11605-021-05181-0","volume":"26","author":"S Komatsu","year":"2022","unstructured":"Komatsu S, Kido M, Kuramitsu K, et al. Impact of Hepatectomy for advanced hepatocellular carcinoma with major portal vein tumor thrombus. J Gastrointest Surg. 2022;26(4):822\u201330. https:\/\/doi.org\/10.1007\/s11605-021-05181-0.","journal-title":"J Gastrointest Surg."},{"issue":"9","key":"13316_CR20","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9","volume":"80","author":"LH Sobin","year":"1997","unstructured":"Sobin LH, Fleming ID. TNM classification of malignant tumor, Fifth edition. Cancer. 1997;80(9):1803\u20134. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19971101)80:9%3c1803::AID-CNCR16%3e3.0.CO;2-9.","journal-title":"Cancer"},{"key":"13316_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru CBJ. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Liver Dis. 1999;19:329\u201338.","journal-title":"Liver Dis."},{"issue":"3","key":"13316_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/hep.510280322","volume":"28","author":"G Manghisi","year":"1998","unstructured":"Manghisi G, Elba S, Mossa A, et al. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology. 1998;28(3):751\u20135. https:\/\/doi.org\/10.1002\/hep.510280322.","journal-title":"Hepatology."},{"key":"13316_CR23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","volume":"56","author":"K Okuda","year":"1985","unstructured":"Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients. Cancer. 1985;56:918\u201328.","journal-title":"Cancer."},{"issue":"6","key":"13316_CR24","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/cncr.10384","volume":"94","author":"TWT Leung","year":"2002","unstructured":"Leung TWT, Tang AMY, Zee B, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the liver Italian program staging system: A study based on 926 patients. Cancer. 2002;94(6):1760\u20139. https:\/\/doi.org\/10.1002\/cncr.10384.","journal-title":"Cancer."},{"issue":"6","key":"13316_CR25","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00432-009-0722-1","volume":"136","author":"BH Zhang","year":"2010","unstructured":"Zhang BH, Wang XH, Yue HY, Ling CQ. A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010;136(6):821\u20137. https:\/\/doi.org\/10.1007\/s00432-009-0722-1.","journal-title":"J Cancer Res Clin Oncol."},{"issue":"3","key":"13316_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s005350300038","volume":"38","author":"M Kudo","year":"2003","unstructured":"Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): Its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003;38(3):207\u201315. https:\/\/doi.org\/10.1007\/s005350300038.","journal-title":"J Gastroenterol."},{"issue":"6","key":"13316_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.21037\/hbsn-19-810","volume":"10","author":"WY Lau","year":"2021","unstructured":"Lau WY, Wang K, Zhang X-P, et al. A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus. Hepatobiliary Surg Nutr. 2021;10(6):782\u201395. https:\/\/doi.org\/10.21037\/hbsn-19-810.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"4","key":"13316_CR28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"JM Llovet","year":"2012","unstructured":"Llovet JM, Ducreux M, Lencioni R, et al. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908\u201343. https:\/\/doi.org\/10.1016\/j.jhep.2011.12.001.","journal-title":"J Hepatol."},{"issue":"11","key":"13316_CR29","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1097\/TP.0000000000003162","volume":"104","author":"AS Soin","year":"2020","unstructured":"Soin AS, Bhangui P, Kataria T, et al. Experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging. Transplantation. 2020;104(11):2334\u201345. https:\/\/doi.org\/10.1097\/TP.0000000000003162.","journal-title":"Transplantation."},{"issue":"8","key":"13316_CR30","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/lt.24782","volume":"23","author":"HJ Choi","year":"2017","unstructured":"Choi HJ, Kim DG, Na GH, et al. The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation. Liver Transplant. 2017;23(8):1023\u201331. https:\/\/doi.org\/10.1002\/lt.24782.","journal-title":"Liver Transplant."},{"issue":"6","key":"13316_CR31","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1245\/s10434-014-3510-3","volume":"21","author":"PH Liu","year":"2014","unstructured":"Liu PH, Lee YH, Hsia CY, et al. Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score analysis. Ann Surg Oncol. 2014;21(6):1825\u201333. https:\/\/doi.org\/10.1245\/s10434-014-3510-3.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"13316_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3350\/cmh.2016.22.1.160","volume":"22","author":"JM Lee","year":"2016","unstructured":"Lee JM, Jang BK, Lee YJ, et al. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis. Clin Mol Hepatol. 2016;22(1):160\u20137. https:\/\/doi.org\/10.3350\/cmh.2016.22.1.160.","journal-title":"Clin Mol Hepatol."},{"issue":"11","key":"13316_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000003015","volume":"95","author":"K Wang","year":"2016","unstructured":"Wang K, Guo WX, Chen MS, et al. Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: A large-scale, multicenter, propensity mathching score analysis. Med (United States). 2016;95(11):1\u201310. https:\/\/doi.org\/10.1097\/MD.0000000000003015.","journal-title":"Med (United States)."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13316-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T09:09:25Z","timestamp":1686215365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13316-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["13316"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13316-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"22 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}